Pharmacodynamics, Pharmacokinetics, Efficacy and Safety of Balugrastim in Pediatric Patients With Solid Tumors

NCT01940601 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Conditions

Solid Tumors

Interventions

DRUG: Balugrastim
DRUG: Filgrastim

Sponsor

Teva Branded Pharmaceutical Products R&D, Inc.